Charanjit Mandair
Biomedicine Business Unit Director @ Eli Lilly and Company
About Charanjit Mandair
Charanjit Mandair serves as the Biomedicine Business Unit Director at Eli Lilly and Company, a position he has held since 2021. With extensive experience in brand management and marketing within the biopharmaceutical industry, he has worked in various roles at Eli Lilly and Merck Sharp & Dohme over the past two decades.